机械分散预测了依赖透析的患者的存活率,左心室喷射分数保留在透析中
Milica Scepanovic1, Ivan Stankovic2,3, Tamara Jemcov4,5
1Department of Cardiology, Clinical Hospital Center Zemun, Vukova 9, Belgrade, 11080, Serbia.
Internal and emergency medicine
|August 13, 2025
概括
在慢性脏病患者接受脏替代疗法与保存的喷射分数,增加左心室机械分散预测死亡率. 这一措施,以及LV质量指数和全球纵向应变,有助于风险分层.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 医疗成像医学成像
背景情况:
- 心血管疾病是慢性病 (CKD) 患者接受脏替代疗法 (RRT) 的主要死亡原因.
- 心声学,特别是在左心室喷射分数 (LVEF) 保存的患者中,可以识别高风险的个体.
- 左心室 (LV) 质量,全球纵向应变 (GLS) 和机械分散是回声心脏学参数,可以提供预后见解.
研究的目的:
- 为了评估LV质量,GLS和RRT患者的机械分散的预后意义,保留LVEF.
- 为了确定这些心声回声学参数是否可以预测这种脆弱人群中所有原因的死亡率.
主要方法:
- 预期随访78名RRT患者,LVEF≥50%,平均55个月.
- 评估LV质量指数 (LVMI) 使用线性测量和身体表面积.
- 将GLS计算为18个分段峰值缩应变值的平均值.
- 从心电图R波到18个LV段的峰值纵向应变间隔的机械分散的测量.
主要成果:
- 在58%的患者中存在LV缩.
- 在随访期间,全因死亡发生在37%的患者中.
- 多变量分析确定了年龄,LVMI,GLS和机械分散作为死亡率的独立预测因素.
结论:
- 增加的机械分散与依赖透析的 LVEF 保存的患者的生存率降低有关.
- 将机械分散与LVMI和GLS相结合可能会增加RRT患者的风险分层.
- 这些心声回声学参数提供了有价值的工具,用于识别这个患者群体中高风险个体.
更多相关视频
06:27A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
2.7K
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
11.3K
相关概念视频
01:30Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:29Heart Failure II: Pathophysiology
41
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
01:22Heart Failure Drugs: Diuretics
484
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
484
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27